by Eclosion Team | May 7, 2019 | Uncategorized
Study meets objective of demonstrating safety and pharmacodynamic response Confirmed excellent safety profile in combination with concomitant medications, with no serious adverse events Opens way for further development in early-onset pediatric population Geneva,...
by Eclosion Team | May 7, 2019 | Uncategorized
Study meets objective of demonstrating safety and pharmacodynamic response Confirmed excellent safety profile in combination with concomitant medications, with no serious adverse events Opens way for further development in early-onset pediatric population Geneva,...
by Eclosion Team | May 2, 2019 | Uncategorized
Top Line Efficacy Results from Phase 2 Primary Biliary Cholangitis (PBC) Trial • 22% reduction in liver stiffness in PBC patients with liver fibrosis compared to a 4% increase for placebo (p=0.038), supports anti-fibrotic mechanism • Statistically significant...